Dr. Fong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 East Jefferson St, Level A
Seattle, WA 98122Phone+1 206-320-2200Fax+1 206-320-2560
Summary
- Dr. Kathryn T. Fong is a neurologist in Seattle, WA and is affiliated with Swedish Neuroscience Institute. She received her medical degree from the University of Texas Southwestern Medical School in Dallas. She completed both Neurology residency and Neuroimmunology/Multiple Sclerosis fellowship at New York Presbyterian/Columbia University Irving Medical Center in New York. She also speaks multiple languages, including French and Spanish, and has special interests in Global Health Neurology and Neuroinfectious Diseases.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 2016 - 2019
University of Texas Southwestern Medical SchoolClass of 2015
Certifications & Licensure
WA State Medical License 2020 - 2026
NY State Medical License 2019 - 2022- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 15 citationsManifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases.Seth N Levin, Shruthi Venkatesh, Katie E. Nelson, Yi Li, Ines M Aguerre
Annals of Clinical and Translational Neurology. 2021-04-01 - 6 citationsFatal COVID-19 in an MS patient on natalizumab: A case reportKathryn Rimmer, Rebecca Farber, Kiran Thakur, Genna Braverman, Dina Podolsky
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2020-08-10 - 48 citationsPotential Neurologic Manifestations of COVID-19Anna S. Nordvig, K. Fong, Joshua Z. Willey, Kiran T. Thakur, Amelia K. Boehme
Neurology. Clinical Practice. 2021-04-01
Journal Articles
- Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consorti...Klineova S, Harel A, Straus Farber R, DeAngelis T, Zhang Y, Hentz R, Ming Leung T, Fong KT, Smith T, Blanck R, Zhovtis-Ryerson L, Multiple Sclerosis and Related Disorders, 10/1/2021
Books/Book Chapters
Abstracts/Posters
- Epidemiology of COVID-19 among persons with neuroimmunological disorders at the Columbia University MS Center in New York CityFong KT, Epstein SE, Thakur KT, Boehme AK, De Jager PL, Vargas WS, Levine L, Riley CS, Straus Farber R, MSVirtual2020, 9/25/2020
- COVID-19 Infection in Patients with Multiple Sclerosis: an observational study by The New York COVID-19 Neuro-Immunology Consortium (NYCNIC)Klineova S, Harel A, Farber R, Zhang Y, DeAngelis T, Leung TM, Fong K, Smith T, Blanck R, Filomena S, Karran M, Gurgova S, Onomichi K, Zhovtis-Ryerson L, MSVirtual2020, 9/25/2020
- Progressive MS patients of older age on ocrelizumab: real-world experience at Columbia University Irving Medical CenterEpstein SE, Fong KT, De Jager PL, Riley CS, Levine L, Vargas WS, Straus Farber R, MS Virtual 2020, 9/11/2020
- Join now to see all
Professional Memberships
- Member
Other Languages
- French, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
